表紙:医薬品受託販売市場の予測(2021年~2031年):タイプ、治療分野、地域・国、主要企業別 - 新型コロナウイルス感染症(COVID-19)からの回復シナリオ
市場調査レポート
商品コード
1026879

医薬品受託販売市場の予測(2021年~2031年):タイプ、治療分野、地域・国、主要企業別 - 新型コロナウイルス感染症(COVID-19)からの回復シナリオ

Pharma Contract Sales Market Report 2021-2031: Forecasts by Type - Personal Promotion, Non-Personal Promotion, Co-Promotion, by Therapeutic, Regional & Leading National Market Analysis, Leading Companies, COVID-19 Recovery Scenarios

出版日: | 発行: Visiongain Ltd | ページ情報: 英文 522 Pages | 納期: 即日から翌営業日

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=156.96円

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

医薬品受託販売市場の予測(2021年~2031年):タイプ、治療分野、地域・国、主要企業別 - 新型コロナウイルス感染症(COVID-19)からの回復シナリオ
出版日: 2021年07月13日
発行: Visiongain Ltd
ページ情報: 英文 522 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

製薬企業の競争力強化のための契約販売への傾倒

製薬企業は、規模の拡大、地理的な範囲の拡大、シナジー効果の実現などにより、競合他社に対する競争力を高めようとしており、医薬品サービス業界は統合が進んでいます。最近の製薬業界におけるM&Aの背景には、外部委託の少ないサービスプロバイダーを求める製薬企業の意向や、サービスポートフォリオの統合だけでなく、従来のCSOサービス以外の補完的な隣接分野への拡大を求める意向があります。

医薬品受託販売は「オールインワン」ソリューション

製薬企業は、利用するアウトソーサーの数を減らそうとする製薬企業の意欲に後押しされて、組織的またはM&Aによる非組織的にサービスの提供範囲を広げ、フルサービスプロバイダーとなって、顧客の業務を簡素化し、アウトソーシング予算の最大のシェアを獲得しています。

サンプルビュー

当レポートでは、世界の医薬品受託販売市場を調査し、市場の概要、市場の成長要因および抑制要因の分析、市場規模の推移と予測、セグメント別の市場シナリオ、市場シェア、新型コロナウイルス感染症(COVID-19)からの各種回復シナリオ、市場機会、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 医薬品受託販売業界の構造

  • 概要
  • 製薬サービスのアウトソーシング
    • 医薬品製造受託機関(CDMO)
    • 契約包装組織(CPO)
    • 契約販売組織(CSO)
    • シリアル化
    • 委託調査機関(CRO)
    • 医薬品製造受託機関(CDMO)

第4章 市場力学

  • 市場の推進要因
    • プラットフォームの拡張
    • 専門知識のアウトソーサーへのシフト
    • 技術利用の増加
  • 市場の抑制要因
    • 薬剤と臨床試験はより複雑になっている
    • 医薬品販売サービスにおける品質の妥協
    • 医薬品販売サービスの品質低下が医薬品受託市場の成長を阻害
  • 市場機会
    • 製薬業界からの圧力により、アウトソーシングがより一般的になりつつある
    • 製薬契約販売は「オールインワン」ソリューション
    • データに支えられたCROサービスへの関心の高まり
  • 課題
    • 研究開発費を削減する必要性
    • その過程でより高価な治療
    • 市場評価の課題:供給と需要の市場
  • SWOT分析
  • PEST分析
  • ポーターファイブフォース

第5章 世界の医薬品受託販売市場の分析

  • 世界市場の見通し
  • 世界の市場規模の推移と予測
    • コロナ以前の市場シナリオ
    • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)
  • 地域の市場規模の推移と予測
    • コロナ以前の市場シナリオ
    • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)

第6章 世界の市場規模の推移と予測:タイプ別

  • セグメントの概要
    • パーソナルプロモーション
    • 非パーソナルプロモーション
    • 共同プロモーション
  • コロナ以前の市場シナリオ
  • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)

第7章 市場規模の推移と予測:パーソナルプロモーション別

  • 商業的側面
  • セグメントの概要
    • 標準的なフィールドフォースの役割
    • 販売展開
    • 空室率
    • ヘルスケア専門教育プログラム
    • キーアカウント管理
  • コロナ以前の市場シナリオ
  • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)

第8章 市場規模の推移と予測:非パーソナルプロモーション別

  • 商業的側面
  • セグメントの概要
    • コンタクトセンター
    • テレディテール
    • 医療コールセンター
    • テレサンプリング
    • オンラインサービス
  • コロナ以前の市場シナリオ
  • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)

第9章 市場規模の推移と予測:共同プロモーション別

  • 商業的側面
  • セグメントの概要
    • マーケティング調査・コンサルティング
    • テリトリー最適化・調整
    • ブランド管理
    • 製品ラインサポート
  • コロナ以前の市場シナリオ
  • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)

第10章 市場規模の推移と予測:治療分野別

  • 商業的側面
  • セグメントの概要
    • 循環器疾患
    • 代謝疾患
    • 腫瘍
    • アルツハイマー病
    • 糖尿病
  • コロナ以前の市場シナリオ
  • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)

第11章 北米の医薬品受託販売市場の分析

  • 北米の市場規模の推移と予測
  • 北米の市場規模の推移と予測:国別
    • コロナ以前の市場シナリオ
    • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)
  • 北米の市場規模の推移と予測:タイプ別
  • 北米の市場規模の推移と予測:パーソナルプロモーション別
  • 北米の市場規模の推移と予測:非パーソナルプロモーション別
  • 北米の市場規模の推移と予測:共同プロモーション別
  • 北米の市場規模の推移と予測:治療分野別
  • 米国
  • カナダ
  • メキシコ

第12章 アジア太平洋地域の医薬品受託販売市場の分析

  • アジア太平洋地域の市場規模の推移と予測
  • アジア太平洋地域の市場規模の推移と予測:国別
    • コロナ以前の市場シナリオ
    • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)
  • アジア太平洋地域の市場規模の推移と予測:タイプ別
  • アジア太平洋地域の市場規模の推移と予測:パーソナルプロモーション別
  • アジア太平洋地域の市場規模の推移と予測:非パーソナルプロモーション別
  • アジア太平洋地域の市場規模の推移と予測:共同プロモーション別
  • アジア太平洋地域の市場規模の推移と予測:治療分野別
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他

第13章 欧州の医薬品受託販売市場の分析

  • 欧州の市場規模の推移と予測
  • 欧州の市場規模の推移と予測:国別
    • コロナ以前の市場シナリオ
    • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)
  • 欧州の市場規模の推移と予測:タイプ別
  • 欧州の市場規模の推移と予測:パーソナルプロモーション別
  • 欧州の市場規模の推移と予測:非パーソナルプロモーション別
  • 欧州の市場規模の推移と予測:共同プロモーション別
  • 欧州の市場規模の推移と予測:治療分野別
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他

第14章 ラテンアメリカ・中東・アフリカの医薬品受託販売市場の分析

  • ラテンアメリカ・中東・アフリカの市場規模の推移と予測
  • ラテンアメリカ・中東・アフリカの市場規模の推移と予測:国別
    • コロナ以前の市場シナリオ
    • コロナ以後の市場シナリオ(V、W、U、L字型の回復分析)
  • ラテンアメリカ・中東・アフリカの市場規模の推移と予測:タイプ別
  • ラテンアメリカ・中東・アフリカの市場規模の推移と予測:パーソナルプロモーション別
  • ラテンアメリカ・中東・アフリカの市場規模の推移と予測:非パーソナルプロモーション別
  • ラテンアメリカ・中東・アフリカの市場規模の推移と予測:共同プロモーション別
  • ラテンアメリカ・中東・アフリカの市場規模の推移と予測:治療分野別
  • ブラジル
  • 南アフリカ
  • サウジアラビア
  • トルコ
  • アラブ首長国連邦
  • その他

第15章 競合情勢

  • 企業の市場シェア分析
  • 主要な事業戦略分析
  • 新製品/サービスの立ち上げ
  • 買収
  • パートナーシップ
  • 拡大
  • 合意
  • 契約

第16章 主要企業のプロファイル

  • Apodi Healthcare Limited
  • CMIC Holdings Co., Ltd
  • Syneos Health Inc.
  • IQVIA Holdings Inc.
  • Marvecs GmbH
  • OnCall LLC
  • Publicis Groupe SA
  • Sofip
  • UDG Healthcare PLC
  • Amplity Health
  • Granard Pharmaceuticals
  • Vanguard Pharma
  • GTS Solution
  • MaBiCo (Contract Sales Organization)
  • Sales Partnerships Inc.
  • QFR Solutions

第17章 結論と推奨事項

第18章 用語集用語

図表

List of Tables

  • Table 1. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 2. Global Pharma Contract Sales Market Snapshot, 2021 & 2031 (US$million, CAGR %)
  • Table 3. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 4. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 5. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 6. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 7. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 8. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 9. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 10. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 11. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 12. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 13. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 14. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 15. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 16. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 17. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 18. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 19. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 20. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 21. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 22. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 23. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 24. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 25. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 26. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 27. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 28. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 29. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 30. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 31. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 32. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 33. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 34. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 35. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 36. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 37. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 38. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 39. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 40. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 41. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 42. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 43. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 44. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shaped Recovery)
  • Table 45. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shaped Recovery)
  • Table 46. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shaped Recovery)
  • Table 47. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shaped Recovery)
  • Table 48. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 49. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 50. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 51. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 52. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 53. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 54. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 55. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 56. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 57. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 58. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 59. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 60. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 61. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 62. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 63. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 64. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 65. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 66. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 67. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 68. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 69. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 70. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 71. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 72. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 73. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 74. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 75. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 76. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 77. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 78. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 79. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 80. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 81. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 82. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 83. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 84. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 85. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 86. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 87. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 88. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 89. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 90. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 91. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 92. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 93. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 94. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 95. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 96. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 97. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 98. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 99. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 100. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 101. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 102. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 103. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 104. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 105. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 106. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 107. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 108. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 109. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 110. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 111. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 112. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 113. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 114. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 115. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 116. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 117. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 118. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 119. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 120. Asia-Pacific Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 121. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 122. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 123. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 124. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 125. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 126. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 127. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 128. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 129. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 130. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 131. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 132. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 133. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 134. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 135. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 136. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 137. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 138. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 139. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 140. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 141. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 142. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 143. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 144. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 145. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 146. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 147. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 148. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 149. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 150. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 151. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 152. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 153. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 154. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 155. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 156. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 157. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shaped Recovery)
  • Table 158. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shaped Recovery)
  • Table 159. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shaped Recovery)
  • Table 160. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shaped Recovery)
  • Table 161. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 162. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 163. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 164. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 165. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 166. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 167. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 168. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 169. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 170. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 171. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 172. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 173. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 174. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 175. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 176. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 177. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 178. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 179. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 180. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 181. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 182. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 183. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 184. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 185. Europe Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 186. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 187. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 188. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 189. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 190. Germany Pharma Contract Sales Market by Country 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 191. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 192. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 193. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 194. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 195. UK Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 196. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 197. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 198. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 199. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 200. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 201. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 202. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 203. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 204. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 205. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 206. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 207. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 208. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 209. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 210. Spain Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 211. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 212. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 213. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 214. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 215. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 216. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 217. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 218. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 219. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 220. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 221. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 222. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V-shaped Recovery)
  • Table 223. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery)
  • Table 224. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery)
  • Table 225. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery)
  • Table 226. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 227. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 228. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 229. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 230. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 231. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 232. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 233. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 234. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 235. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 236. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 237. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 238. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 239. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 240. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 241. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 242. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 243. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 244. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 245. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 246. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 247. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 248. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 249. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 250. LAMEA Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 251. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 252. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 253. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 254. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 255. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 256. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 257. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 258. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 259. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 260. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 261. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 262. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 263. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 264. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 265. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 266. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 267. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 268. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 269. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 270. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 271. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 272. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 273. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 274. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 275. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 276. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
  • Table 277. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
  • Table 278. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
  • Table 279. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
  • Table 280. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
  • Table 281. New Product/Service Launch Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
  • Table 282. Acquisition Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
  • Table 283. Partnership Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
  • Table 284. Collaboration Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
  • Table 285. Expansion Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
  • Table 286. Agreement Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
  • Table 287. Contract Strategy Adopted by Key Players in Global Pharma Contract Sales Market, 2018-2021
  • Table 288. Apodi Healthcare Limited.: Company Information
  • Table 289. Apodi Healthcare Limited.: Company Product and Service
  • Table 290. CMIC Holdings Co., Ltd.: Company Information
  • Table 291. CMIC Holdings Co., Ltd.: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Table 292. CMIC Holdings Co., Ltd.: Company Service Benchmarking
  • Table 293. CMIC Holdings Co., Ltd.: Company Recent Developments till Apr,2021
  • Table 294. Syneos Health Inc.: Company Information
  • Table 295. Syneos Health Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Table 296. Syneos Health Inc.: Company Product and Service Benchmarking
  • Table 297. Syneos Health Inc.: Company Recent Developments till May,2021
  • Table 298. IQVIA Holdings Inc.: Company Information
  • Table 299. IQVIA Holdings Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Table 300. IQVIA Holdings Inc.: Company Product and Service Benchmarking
  • Table 301. IQVIA Holdings Inc.: Company Recent Developments till Feb,2021
  • Table 302. Marvecs GmbH .: Company Information
  • Table 303. Marvecs GmbH .: Company Product and Service Benchmarking
  • Table 304. Oncall LLC.: Company Information
  • Table 305. OnCall LLC.: Company Product and Service Benchmarking
  • Table 306. Publicis Groupe SA .: Company Information
  • Table 307. Publicis Groupe SA Revenue 2016-2020 (US$Mn, AGR %)
  • Table 308. Publicis Groupe SA Product and Service
  • Table 309. Publicis Groupe SA Recent Developments till Apr,2021
  • Table 310. Sofip: Company Information
  • Table 311. Sofip: Company Product and Service Benchmarking
  • Table 312. UDG Healthcare PLC: Company Information
  • Table 313. UDG Healthcare PLC: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Table 314. UDG Healthcare PLC: Company Product and Service
  • Table 315. UDG Healthcare PLC.: Company Recent Developments till Feb,2021
  • Table 316. Amplity Health.: Company Information
  • Table 317. Amplity Health.: Company Product and Service Benchmarking
  • Table 318. Amplity Health.: Company Recent Developments till Feb,2021
  • Table 319. Granard Pharmaceuticals.: Company Information
  • Table 320. Granard Pharmaceuticals: Company Product and Service
  • Table 321. Vanguard Pharma.: Company Information
  • Table 322. Vanguard Pharma.: Company Product and Service
  • Table 323. GTS Solution : Company Information
  • Table 324. GTS Solution : Company Product and Service
  • Table 325. MaBiCo (Contract Sales Organization) .: Company Information
  • Table 326. MaBiCo (Contract Sales Organization) .: Company Product and Service
  • Table 327. Sales Partnerships Inc..: Company Information
  • Table 328. Sales Partnerships Inc..: Company Product and Service
  • Table 329. QFR Solutions.: Company Information
  • Table 330. QFR Solutions.: Company Product and Service
  • Table 331. Glossary Terms

List of Figures

  • Figure 1. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))
  • Figure 2. Global Pharma Contract Sales Market Segmentation
  • Figure 3. SWOT Analysis
  • Figure 4. PEST Analysis
  • Figure 5. Porter Five Forces Analysis
  • Figure 6. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))
  • Figure 7. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 8. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 9. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 10. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 11. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))
  • Figure 12. Global Pharma contract sales Market by Region, 2021, 2026, 2031 (%)
  • Figure 13. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 14. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 15. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 16. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 17. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))
  • Figure 18. Global pharma contract salesMarket by EOR Type, 2021, 2026, 2031 (%)
  • Figure 19. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 20. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 21. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 22. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 23. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 24. Global Pharma contract sales EOR Market by Personal Promotion, 2021, 2026, 2031 (%)
  • Figure 25. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 26. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 27. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 28. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery) (L-Shape Recovery)
  • Figure 29. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 30. Global Pharma Contract Sales Market by non-Personal Promotion, 2021, 2026, 2031 (%)
  • Figure 31. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 32. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 33. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 34. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 35. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 36. Global Pharma Contract sales Market by Co-Promotion, 2021, 2026, 2031 (%)
  • Figure 37. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 38. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 39. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 40. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 41. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))
  • Figure 42. Global Pharma Contract sales Market by Theraputic, 2021, 2026, 2031 (%)
  • Figure 43. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 44. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 45. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 46. Global Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 47. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))
  • Figure 48. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 49. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 50. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 51. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 52. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 53. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 54. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 55. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 56. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 57. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))
  • Figure 58. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 59. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 60. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 61. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 62. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 63. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 64. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 65. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 66. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 67. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%)
  • Figure 68. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%)(V-Shape Recovery)
  • Figure 69. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%)(W-Shape Recovery)
  • Figure 70. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%)(U-Shape Recovery)
  • Figure 71. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%)(L-Shape Recovery)
  • Figure 72. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 73. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 74. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 75. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 76. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 77. North America Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))
  • Figure 78. North America Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 79. North America Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 80. North America Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 81. North America Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 82. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 83. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 84. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 85. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 86. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 87. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR(%))
  • Figure 88. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR(%))(V-Shape Recovery)
  • Figure 89. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR(%))(W-Shape Recovery)
  • Figure 90. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR(%))(U-Shape Recovery)
  • Figure 91. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 92. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 93. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 94. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 95. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))
  • Figure 96. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 97. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 98. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 99. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 100. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 101. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 102. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 103. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 104. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 105. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))
  • Figure 106. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 107. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 108. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 109. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 110. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 111. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 112. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 113. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 114. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 115. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 116. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 117. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 118. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 119. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 120. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 121. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 122. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 123. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 124. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 125. Asia-Pacific Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))
  • Figure 126. Asia-Pacific Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 127. Asia-Pacific Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 128. Asia-Pacific Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 129. Asia-Pacific Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 130. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 131. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 132. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 133. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 134. China Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 135. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 136. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 137. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 138. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 139. India Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 140. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 141. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 142. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 143. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 144. Japan Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 145. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 146. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 147. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 148. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 149. South Korea Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 150. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 151. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 152. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 153. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 154. Australia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 155. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 156. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 157. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 158. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 159. Rest of Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 160. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))
  • Figure 161. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 162. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 163. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 164. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 165. Europe Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))
  • Figure 166. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%)) (V-Shaped Recovery)
  • Figure 167. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%)) (W- Shaped Recovery)
  • Figure 168. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%)) (U-Shaped Recovery)
  • Figure 169. Europe Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%)) (L-Shaped Recovery)
  • Figure 170. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))
  • Figure 171. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 172. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 173. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 174. Europe Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 175. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 176. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 177. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 178. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 179. Europe Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 180. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 181. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 182. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 183. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 184. Europe Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 185. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 186. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 187. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 188. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 189. Europe Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 190. Europe Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))
  • Figure 191. Europe Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 192. Europe Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 193. Europe Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 194. Europe Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 195. Germany Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 196. Germany Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 197. Germany Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 198. Germany Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 199. Germany Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 200. UK Pharma Contract Sales Market by Country,2021-2031 (USD Mn, AGR (%))
  • Figure 201. UK Pharma Contract Sales Market by Country,2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 202. UK Pharma Contract Sales Market by Country,2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 203. UK Pharma Contract Sales Market by Country,2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 204. UK Pharma Contract Sales Market by Country,2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 205. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 206. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 207. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 208. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 209. France Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 210. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 211. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 212. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 213. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 214. Italy Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 215. Spain Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))
  • Figure 216. Spain Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 217. Spain Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 218. Spain Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 219. Spain Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 220. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))
  • Figure 221. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 222. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 223. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 224. Rest of Europe Pharma Contract Sales Market by Country,, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 225. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))
  • Figure 226. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 227. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 228. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 229. LAMEA Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 230. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 231. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 232. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 233. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 234. LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 235. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))
  • Figure 236. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 237. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 238. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 239. LAMEA Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 240. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 241. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 242. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 243. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 244. LAMEA Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 245. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 246. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 247. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 248. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 249. LAMEA Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 250. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))
  • Figure 251. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 252. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 253. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 254. LAMEA Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 255. LAMEA Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))
  • Figure 256. LAMEA Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 257. LAMEA Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 258. LAMEA Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 259. LAMEA Pharma Contract Sales Market by Theraputic, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 260. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 261. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 262. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 263. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 264. Brazil Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 265. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 266. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 267. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 268. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 269. South Africa Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 270. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 271. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 272. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 273. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 274. Saudi Arabia Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 275. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 276. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 277. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 278. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 279. Turkey Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 280. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 281. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 282. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 283. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 284. UAE Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 285. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))
  • Figure 286. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(V-Shape Recovery)
  • Figure 287. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(W-Shape Recovery)
  • Figure 288. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(U-Shape Recovery)
  • Figure 289. Rest of LAMEA Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%))(L-Shape Recovery)
  • Figure 290. Pharma Contract Sales Market by Company Share, 2020 (%)
  • Figure 291. Pharma Contract Sales Market by Key Business Strategy, 2018-2021 (%)
  • Figure 292. CMIC Holdings Co., Ltd.: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Figure 293. CMIC Holdings Co., Ltd.: Company Operating Income 2016-2020 (US$Mn, AGR %)
  • Figure 294. CMIC Holdings Co., Ltd.: Company Net Income 2016-2020 (US$Mn, AGR %)
  • Figure 295. CMIC Holdings Co., Ltd: Company EBITDA 2016-2020 (US$Mn, AGR %)
  • Figure 296. Syneos Health Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Figure 297. Syneos Health Inc.: Company Operating Income 2016-2020 (US$Mn, AGR %)
  • Figure 298. Syneos Health Inc.: Company Net Income 2016-2020 (US$Mn, AGR %)
  • Figure 299. Syneos Health Inc.: Company EBITDA 2016-2020 (US$Mn, AGR %)
  • Figure 300. IQVIA Holdings Inc.: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Figure 301. IQVIA Holdings Inc.: Company Operating Income 2016-2020 (US$Mn, AGR %)
  • Figure 302. IQVIA Holdings Inc.: Company Net Income 2016-2020 (US$Mn, AGR %)
  • Figure 303. IQVIA Holdings Inc.: Company EBITDA 2016-2020 (US$Mn, AGR %)
  • Figure 304. Publicis Groupe SA Revenue 2016-2020 (US$Mn, AGR %)
  • Figure 305. Publicis Groupe SA Operating Income 2016-2020 (US$Mn, AGR %)
  • Figure 306. Publicis Groupe SA Net Income 2016-2020 (US$Mn, AGR %)
  • Figure 307. Publicis Groupe SA EBITDA 2016-2020 (US$Mn, AGR %)
  • Figure 308. UDG Healthcare PLC: Company Revenue 2016-2020 (US$Mn, AGR %)
  • Figure 309. UDG Healthcare PLC: Company Operating Income 2016-2020 (US$Mn, AGR %)
  • Figure 310. UDG Healthcare PLC: Company Net Income 2016-2020 (US$Mn, AGR %)
  • Figure 311. UDG Healthcare PLC: Company EBITDA 2016-2020 (US$Mn, AGR %)

List of Companies Profiled in the report:

  • Amplity Health
  • Apodi Healthcare Limited
  • CMIC Holdings Co., Ltd
  • Granard Pharmaceuticals
  • GTS Solution
  • IQVIA Holdings Inc.
  • MaBiCo (Contract Sales Organization)
  • Marvecs GmbH
  • OnCall LLC
  • Publicis Groupe SA
  • QFR Solutions
  • Sales Partnerships Inc.
  • Sofip
  • Syneos Health Inc.
  • UDG Healthcare PLC
  • Vanguard Pharma

List of Other Companies Mentioned in the report:

  • AbbVie Inc Company
  • Aenova Group Company
  • Ajinomoto Bio-Pharma Services Company
  • Alcami Corporation Company
  • Alkermes Biotechnology company
  • Almac Group Company
  • Aurobindo Pharma Ltd.
  • Avid Bioservices Inc.
  • Baxter Biopharma Solutions Company
  • Bayer AG Company
  • Biocon Limited Company
  • Biomay AG Company
  • Biophore India Pharmaceuticals Private Limited Company
  • Bora Pharmaceuticals Company
  • C.H. Boehringer Sohn AG & Ko. KG Company
  • Cambrex Corporation Company
  • Cardinal Health, Inc. Company
  • Catalent Pharma Solutions Inc.
  • Cepia Sanofi Company (Parental of Sanofi)
  • Charles River Laboratories International, Inc. Company
  • Consort Medical plc
  • Corden Pharma International Company
  • Daito Pharmaceutical Co., Ltd. Company
  • Delpharm SAS Company
  • Divi's Laboratories Ltd
  • DPT Laboratories, Ltd. (Mylan N.V.) Company
  • Dr. Reddy's Laboratories Company
  • Evonik Degussa Company
  • F. Hoffmann-La Roche Ltd
  • Famar S.A. Company
  • Fareva Pharmaceuticals Company
  • Fujifilm Diosynth Biotechnologies (Merck & co subsidiaries)
  • GlaxoSmithKline Pharmaceutical Company
  • Huapont Life Sciences Co Ltd Company
  • Koninklijke DSM N.V. (Royal DSM) Company
  • Lonza AG Company
  • Nipro Corporation
  • Pfizer Company
  • Recipharm AB Company
  • SAFC Biosciences (Merck KGaA Subsidiaries) Company
  • Samsung Biologics Company
  • Siegfried Holding Company
  • Strides Pharma Science Limited Company
  • Teva Pharmaceuticals Company
  • Therapure Biopharma, Inc. Company
  • Thermo Fisher Scientific Inc.
  • UPM Pharmaceuticals Company
  • Vetter Pharma Company
  • WuXi AppTec Company
  • Zhejiang Hisun Pharmaceutical Company

List of Associations Mentioned in the Report:

  • International Pharmaceutical Federation
  • European Pharmaceutical Union
  • Pharmaceutical Group of the European Union
  • Australian College of Pharmacy
  • Chinese Pharmaceutical Association
  • Danish Association of Pharmaconomists
  • Pharmaceutical Association of Israel
  • Pharmaceutical Society of New Zealand
  • Norwegian Pharmacy Association
  • Pakistan Pharmacists Society
  • Alliance for Pharmacy Compounding
  • American Association of Colleges of Pharmacy (AACP)
  • Academy of Managed Care Pharmacy (AMCP)
  • American Pharmacists Association (APhA)
  • American Society of Consultant Pharmacists (ASCP)
  • American Society of Health-System Pharmacist (ASHP)
  • National Association of Boards of Pharmacy (NABP)
  • National Association of Chain Drug Stores (NACDS)
  • National Alliance of State Pharmacy Association (NASPA)
  • National Community Pharmacists Association (NCPA)
  • American College of Apothecaries
  • American Herbal Pharmacopoeia
  • American Society of Automation in Pharmacy
  • Accreditation Council for Pharmacy Education
  • Board of Pharmaceutical Specialties
  • Consumer Healthcare Products Association
  • Drug Information Association
  • The Generic Pharmaceutical Association
  • Healthcare Distribution Management Association
  • Institute for Safe Medication Practices
  • National Association of State Controlled Substances Authorities
  • National Council for Prescription Drug Programs
  • Pharmacy Technician Certification Board
  • Pharmaceutical Research and Manufacturers of America
  • Pharmacy Services Technical Advisory Coalition
  • United States Pharmacopeia
目次
Product Code: PHA1137

Title:
Pharma Contract Sales Market Report 2021-2031
Forecasts by Type (Personal Promotion (Standard Field Force Roles, Sales Deployment, Vacancy Coverage, HCP Educational Programs, Key Account Management, Other), Non-Personal Promotion (Contact Center, Teledetailing, Medical Call Centers, Telesampling, Online Services), Co-Promotion (Marketing Research and Consulting, Product Commercialization, Territory Optimization & Alignment, Brand Management, Mature Product Line Support, Rest All CSO Services)), by Theraputic (Cardiovascular Disease, Metabolic Disorders, Oncology, Alzheimer's Disease, Diabetes, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Pharma Contract Sales Companies AND COVID-19 Recovery Scenarios.

The Pharma Contract Sales Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Inclination Of Pharma Companies Towards Contract Sales To Gain A Competitive Edge

The pharma services industry is consolidating as companies aim to gain a competitive edge over their competitors by increasing size, expanding geographical reach, and achieving synergies. Recent M&A in the sub-sector motivated by pharma's desire to work with less outsourced service providers, as well as a desire to consolidate but also broaden service portfolios outside of conventional CSO services into complementary adjacent fields. Ashfield's entrance into the commercialisation consulting and marketing industries is an example of this.

The Pharma Contract Sales Is "All-In-One" Solution

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers' operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use. For example, The Apodi Healthcare is providing wide range of solutions such as for human-centred, requiring the deployment of promotional resources and/or healthcare professionals, and are often aided by cutting-edge technology. Their services are mainly focused on educating and promoting particular drugs to healthcare professionals, as well as providing patient programmes that help their strategies make a real difference by improving patients' lives, funding the NHS, and generating revenue for their clients.

What Are These Questions You Should Ask Before Buying A Market Research Report?

  • How is the pharma contract sales market evolving?
  • What is driving and restraining the pharma contract sales market?
  • How will each pharma contract sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2031?
  • How will the market shares for each pharma contract sales submarket develop from 2021 to 2031?
  • What will be the main driver for the overall market from 2021 to 2031?
  • Will leading pharma contract sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2031 and which geographical region will lead the market in 2031?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the pharma contract sales projects for these leading companies?
  • How will the industry evolve during the period between 2019 and 2031?What are the implication of pharma contract sales projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the pharma contract sales market?
  • Where is the pharma contract sales market heading? And how can you ensure you are at the forefront of the market?
  • What can be the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path? C-suite?

You need to discover how this will impact the pharma contract sales market today, and over the next 10 years:

  • Our 522-page report provides 331 tables and 311 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • Contains in-depth analyse of global, regional and national sales and growth
  • Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the pharma contract sales market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma contract sales prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.

Global Pharma Contract Sales Market (COVID Impact Analysis) by Type

  • Personal Promotion
  • Non-Personal Promotion
  • Co-Promotion

Global Pharma Contract Sales Market (COVID Impact Analysis) by Personal Promotion

  • Standard Field Force Roles
  • Sales Deployment
  • Vacancy Coverage
  • HCP Educational Programs
  • Key Account Management
  • Other Personal Promotion Services

Global Pharma Contract Sales Market (COVID Impact Analysis) by Non-Personal Promotion

  • Contact Center
  • Teledetailing
  • Medical Call Centers
  • Telesampling
  • Online Services

Global Pharma Contract Sales Market (COVID Impact Analysis) by Co-Promotion

  • Marketing Research and Consulting
  • Product Commercialization
  • Territory Optimization & Alignment
  • Brand Management
  • Mature Product Line Support
  • Rest All CSO Services

Global Pharma Contract Sales Market (COVID Impact Analysis) by Therapeutic

  • Cardiovascular Disease
  • Metabolic Disorders
  • Oncology
  • Alzheimer's Disease
  • Diabetes
  • Other Therapeutics

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:

  • North America Pharma Contract Sales Market, 2021 to 2031 Market Outlook
  • U.S. Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Canada Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Mexico Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Europe Pharma Contract Sales Market, 2021 to 2031 Market Outlook
  • Germany Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Spain Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • United Kingdom Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • France Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Italy Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Rest of Europe Market Forecast & COVID Impact Analysis
  • Asia Pacific Pharma Contract Sales Market, 2021 to 2031 Market Outlook
  • China Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Japan Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • India Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Australia Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • South Korea Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Rest of Asia Pacific Market Forecast & COVID Impact Analysis
  • LAMEA Pharma Contract Sales Market, 2021 to 2031 Market Outlook
  • Brazil Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Turkey Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Saudi Arabia Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • South Africa Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • UAE Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
  • Rest of Latin America, Middle East and Africa

SAMPLE VIEW

The report also includes profiles and for some of the leading companies in the Pharma Contract Sales Market, 2021 to 2031, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Amplity Health
  • Apodi Healthcare Limited
  • CMIC Holdings Co., Ltd
  • Granard Pharmaceuticals
  • GTS Solution
  • IQVIA Holdings Inc.
  • MaBiCo (Contract Sales Organization)
  • Marvecs GmbH
  • OnCall LLC
  • Publicis Groupe SA
  • QFR Solutions
  • Sales Partnerships Inc.
  • Sofip
  • Syneos Health Inc.
  • UDG Healthcare PLC
  • Vanguard Pharma

Overall world revenue for Pharma Contract Sales Market, 2021 to 2031 in terms of value the market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Pharma Contract Sales Market, 2021 to 2031 Market report helps you?

In summary, our 520+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Pharma Contract Sales Market, 2021 to 2031 Market, with forecasts for type, Personal Promotion, Non-Personal Promotion, Co-Promotion, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 4 regional and 20 key national markets - See forecasts for the Pharma Contract Sales Market, 2021 to 2031 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 16 of the major companies involved in the Pharma Contract Sales Market, 2021 to 2031 Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Pharma Contract Sales Market, 2021 to 2031 Market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Pharma Contract Sales Market
  • 1.2 Global Pharma Contract Sales Market Overview
  • 1.3 What are the Objectives of this Report?
  • 1.4 What is the Scope of the Report?
  • 1.5 Pharma Contract Sales Market Definition
  • 1.6 Why You Should Read This Report
  • 1.7 What This Report Delivers
  • 1.8 Key Questions Answered By This Analytical Report Include:
  • 1.9 Who is This Report for?
  • 1.10 Research Methodology
    • 1.10.1 Primary Research
    • 1.10.2 Secondary Research
    • 1.10.3 Market Evaluation & Forecasting Methodology
  • 1.11 Frequently Asked Questions (FAQs)
  • 1.12 Associated Visiongain Reports
  • 1.13 About Visiongain

2 Executive Summary

3 Pharma Contract Sales Industry Structure

  • 3.1 Overview
  • 3.2 Outsource Pharma Services
    • 3.2.1 Contract Development and Manufacturing Organisations (CDMOs)
    • 3.2.2 Contract Packaging Organisations (CPOs)
    • 3.2.3 Contract Sales Organisations (CSOs)
    • 3.2.4 Serialisation
    • 3.2.5 Contract Research Organisations (CROs)
    • 3.2.6 Contract Development and Manufacturing Organisations (CDMOs)

4 Global Market Dynamics

  • 4.1 Market Driving Factors
    • 4.1.1 Extension Of The Platform
    • 4.1.2 Expertise Shift To Outsourcers
    • 4.1.3 Increased Technological Utilisation
  • 4.2 Market Restraining Factors
    • 4.2.1 Drugs And Clinical Trials Are Becoming More Complex.
    • 4.2.2 Quality Compromise In Pharma Sales Services
    • 4.2.3 Restricts Growth Of The Submarket Of Contract Pharma Sakes API
  • 4.3 Opportunities in the Global Market
    • 4.3.1 Outsourcing Is Becoming More Common Due to Pressures from The Pharmaceutical Industry.
    • 4.3.2 The Pharma Contract Sales Is "All-In-One" Solution
    • 4.3.3 Increased Interest In CRO Services Fuelled By Data
  • 4.4 Challenges in the Global Market
    • 4.4.1 The Need Of Reducing R&D Spending
    • 4.4.2 More Expensive Treatments In The Process
    • 4.4.3 Market Evaluation Challenges: Supply Vs Demand Market
  • 4.5 SWOT Analysis
    • 4.5.1 Strengths
    • 4.5.2 Weakness
    • 4.5.3 Opportunities
    • 4.5.4 Threats
  • 4.6 PEST Analysis
    • 4.6.1 Political
    • 4.6.2 Economical
    • 4.6.3 Sociocultural
    • 4.6.4 Technology
  • 4.7 Porter Five Forces
    • 4.7.1 What is Porter Five (5) Forces
    • 4.7.2 Threat of New Entrants (Low to Moderate)
    • 4.7.3 Rivalry Among the Existing Players (High)
    • 4.7.4 Bargaining Power of Suppliers (Low)
    • 4.7.5 Threats from Substitute Products (Low to Moderate)
    • 4.7.6 Bargaining Power of Buyers (High)

5 Global Pharma Contract Sales Market Analysis

  • 5.1 Global Market Outlook
  • 5.2 Global Market Size Estimation and Forecast
    • 5.2.1 Pre-COVID-19 Market Scenario
    • 5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 5.3 Regional Market Size Estimation and Forecast
    • 5.3.1 Pre-COVID-19 Market Scenario
    • 5.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Global Market Size Estimation and Forecast By Type

  • 6.1 Segment Overview
    • 6.1.1 Personal Promotion
    • 6.1.2 Non-Personal Promotion
    • 6.1.3 Co-Promotion
  • 6.2 Pre-COVID-19 Market Scenario
  • 6.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

7 Global Market Size Estimation and Forecast By Personal Promotion

  • 7.1 Commercial Aspects
  • 7.2 Segment Overview
    • 7.2.1 Standard Field Force Roles
    • 7.2.2 Sales Deployment
    • 7.2.3 Vacancy Coverage
    • 7.2.4 Health Care Professional Educational Programs
    • 7.2.5 Key Account Management
  • 7.3 Pre-COVID-19 Market Scenario
  • 7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

8 Global Market Size Estimation and Forecast By Non- Personal Promotion

  • 8.1 Commercial Aspects
  • 8.2 Segment Overview
    • 8.2.1 Contact Center
    • 8.2.2 Teledetailing
    • 8.2.3 Medical Call Centers
    • 8.2.4 Telesampling
    • 8.2.5 Online Services
  • 8.3 Pre-COVID-19 Market Scenario
  • 8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

9 Global Market Size Estimation and Forecast By Co-Promotion

  • 9.1 Commercial Aspects
  • 9.2 Segment Overview
    • 9.2.1 Marketing Research and Consulting
    • 9.2.2 Territory Optimization & Alignment
    • 9.2.3 Brand Management
    • 9.2.4 Mature Product Line Support
  • 9.3 Pre-COVID-19 Market Scenario
  • 9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 Global Market Size Estimation and Forecast By Therapeutic

  • 10.1 Commercial Aspects
  • 10.2 Segment Overview
    • 10.2.1 Cardiovascular Disease
    • 10.2.2 Metabolic Disorders
    • 10.2.3 Oncology
    • 10.2.4 Alzheimer's Disease
    • 10.2.5 Diabetes
  • 10.3 Pre-COVID-19 Market Scenario
  • 10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

11 North America Market Size Estimation and Forecast

  • 11.1 North America Market Size Estimation and Forecast
    • 11.1.1 Changing Pharmaceutical And Health Industry Dynamics Led To Innovation in the North America Region
    • 11.1.2 Pre-COVID-19 Market Scenario
    • 11.1.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.2 Country Market Size Estimation and Forecast
    • 11.2.1 Pre-COVID-19 Market Scenario
    • 11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.3 North America Market Size Estimation and Forecast By Type
    • 11.3.1 Pre-COVID-19 Market Scenario
    • 11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.4 North America Market Size Estimation and Forecast By Personal Promotion
    • 11.4.1 Pre-COVID-19 Market Scenario
    • 11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.5 North America Market Size Estimation and Forecast By Non- Personal Promotion
    • 11.5.1 Pre-COVID-19 Market Scenario
    • 11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.6 North America Market Size Estimation and Forecast By Co-Promotion
    • 11.6.1 Pre-COVID-19 Market Scenario
    • 11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.7 North America Market Size Estimation and Forecast By Therapeutic
    • 11.7.1 Pre-COVID-19 Market Scenario
    • 11.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.8 U.S. Market Analysis
    • 11.8.1 The US is One of the Most Important Pharmaceutical Markets Due to Presence of Largest Pharmaceutical Firms
    • 11.8.2 U.S. Regulations Regarding Contract Sales
    • 11.8.3 Pre-COVID-19 Market Scenario
    • 11.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.9 Canada Market Analysis
    • 11.9.1 Canada Market Consists Of A Variety Of Sub-Sectors Serving Various Segments Of The Industry
    • 11.9.2 Pharma Sales Are Scattered Among Toronto, Montreal And Vancouver Metropolitan Areas
    • 11.9.3 Pre-COVID-19 Market Scenario
    • 11.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 11.10 Mexico Market Analysis
    • 11.10.1 Mexico With Over 350 Local And Cross-Border Businesses Producing Pharmaceuticals Influence US Market
    • 11.10.2 Pre-COVID-19 Market Scenario
    • 11.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

12 Asia-Pacific Market Size Estimation and Forecast

  • 12.1 Asia-Pacific Market Size Estimation and Forecast
    • 12.1.1 The Rise Of Pharma Contract Sales Organisations In The APAC Is Guided By The Changing Market Access, Repayment Policies And Competitive Environment
    • 12.1.2 In Pharmaceutical Investment In The World, Asia Is The Fastest Expanding Region
    • 12.1.3 Pre-COVID-19 Market Scenario
    • 12.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.2 Country Market Size Estimation and Forecast
    • 12.2.1 Pre-COVID-19 Market Scenario
    • 12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.3 Asia-Pacific Market Size Estimation and Forecast By Type
    • 12.3.1 Pre-COVID-19 Market Scenario
    • 12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.4 Asia-Pacific Market Size Estimation and Forecast By Personal Promotion
    • 12.4.1 Pre-COVID-19 Market Scenario
    • 12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.5 Asia-Pacific Market Size Estimation and Forecast By Non- Personal Promotion
    • 12.5.1 Pre-COVID-19 Market Scenario
    • 12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.6 Asia-Pacific Market Size Estimation and Forecast By Co-Promotion
    • 12.6.1 Pre-COVID-19 Market Scenario
    • 12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.7 Asia-Pacific Market Size Estimation and Forecast By Therapeutic
    • 12.7.1 Pre-COVID-19 Market Scenario
    • 12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.8 China Market Analysis
    • 12.8.1 Ever Growing Pharma Industry in China
    • 12.8.2 Driving Element Behind The Tremendous Outsourcing Growth Of China
  • 12.9 Pre-COVID-19 Market Scenario
    • 12.9.1 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.10 India Market Analysis
    • 12.10.1 Strong Foothold of Pharma Companies In India
    • 12.10.2 Evolving Healthcare System in the Country
    • 12.10.3 Pre-COVID-19 Market Scenario
    • 12.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.11 Japan Market Analysis
    • 12.11.1 Steady Pharma Growth and Development In Japan Will Drive Contract Sales Market
    • 12.11.2 Pool of Opportunities in Japan for CSOs
    • 12.11.3 Pre-COVID-19 Market Scenario
    • 12.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.12 South Korea Market Analysis
    • 12.12.1 South Korea Hopes To Win 6% Of Global Pharmaceutical And Medical Device Manufacturing By 2030
    • 12.12.2 Pre-COVID-19 Market Scenario
    • 12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.13 Australia Market Analysis
    • 12.13.1 Pharmaceutical Market In Australia Represents A Knowledge-Based, Technology-Intensive Industry
    • 12.13.2 Number Of Opportunities Open To Companies Hoping To Invest In The Australian Pharmaceutical Industry
    • 12.13.3 Pre-COVID-19 Market Scenario
    • 12.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 12.14 Rest of Asia-Pacific Market Analysis
    • 12.14.1 More Launches, Increased Payer and Regulatory Scrutiny, And Increased Rivalry Have Resulted In Shorter Sales Cycles In Asia-Pacific
    • 12.14.2 Pre-COVID-19 Market Scenario
    • 12.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

13 Europe Market Size Estimation and Forecast

  • 13.1 Region Overview
    • 13.1.1 Outsourced Products Have Grown Beyond Their Original Focus And Now Address A Wide Range Of Company Demands
    • 13.1.2 Europe Is Emerging As Competitive Sources Of Contract Production And Sales Services
    • 13.1.3 Growing Presence of Contract Sales development and manufacturing (CDMOs) companies
  • 13.2 Europe Market Size Estimation and Forecast
    • 13.2.1 Pre-COVID-19 Market Scenario
    • 13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.3 Country Market Size Estimation and Forecast
    • 13.3.1 Pre-COVID-19 Market Scenario
    • 13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.4 Europe Market Size Estimation and Forecast By Type
    • 13.4.1 Pre-COVID-19 Market Scenario
    • 13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.5 Europe Market Size Estimation and Forecast By Personal Promotion
    • 13.5.1 Pre-COVID-19 Market Scenario
    • 13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.6 Europe Market Size Estimation and Forecast By Non- Personal Promotion
    • 13.6.1 Pre-COVID-19 Market Scenario
    • 13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.7 Europe Market Size Estimation and Forecast By Co-Promotion
    • 13.7.1 Pre-COVID-19 Market Scenario
    • 13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.8 Europe Market Size Estimation and Forecast By Therapeutic
    • 13.8.1 Pre-COVID-19 Market Scenario
    • 13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.9 Germany Market Analysis
    • 13.9.1 Germany Is The World's Largest Market For Biosimilar Pharmaceuticals Creates Opportunities for CSOs
    • 13.9.2 Pre-COVID-19 Market Scenario
    • 13.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.10 UK Market Analysis
    • 13.10.1 Challenges in the UK Pharmaceutical Market
    • 13.10.2 Pre-COVID-19 Market Scenario
    • 13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.11 France Market Analysis
    • 13.11.1 France Is Europe's Third-Largest Market And One Of The Biggest Pharmaceutical Users In The World
    • 13.11.2 Not Every Pharmaceutical Company Prefers Contract Sales In France
    • 13.11.3 Pre-COVID-19 Market Scenario
    • 13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.12 Italy Market Analysis
    • 13.12.1 Pharma Contract Sales Is One of the Important Pharma Segment in Italy
    • 13.12.2 Pre-COVID-19 Market Scenario
    • 13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.13 Spain Market Analysis
    • 13.13.1 Spain's Pharmaceutical Industry Has Always Been One Of Spain's Main Pillars In High-Tech Production.
    • 13.13.2 Pre-COVID-19 Market Scenario
    • 13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 13.14 Rest of Europe Market Analysis
    • 13.14.1 Outsourcing Has Increased Significantly In Rest Of Europe
    • 13.14.2 Pre-COVID-19 Market Scenario
    • 13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

14 LAMEA Market Size Estimation and Forecast

  • 14.1 Regional Overview
    • 14.1.1 Lack Of Substantial Expertise And Costly Capabilities Are Main Challenges In The Region
    • 14.1.2 The Outbreak Of Coronavirus Has A Significant Effect On Third-Party Service Providers In Biotech And Pharmaceuticals
  • 14.2 LAMEA Market Size Estimation and Forecast
    • 14.2.1 Pre-COVID-19 Market Scenario
    • 14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.3 Country Market Size Estimation and Forecast
    • 14.3.1 Pre-COVID-19 Market Scenario
    • 14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.4 LAMEA Market Size Estimation and Forecast By Type
    • 14.4.1 Pre-COVID-19 Market Scenario
    • 14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.5 LAMEA Market Size Estimation and Forecast By Personal Promotion
    • 14.5.1 Pre-COVID-19 Market Scenario
    • 14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.6 LAMEA Market Size Estimation and Forecast By Non- Personal Promotion
    • 14.6.1 Pre-COVID-19 Market Scenario
    • 14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.7 LAMEA Market Size Estimation and Forecast By Co-Promotion
    • 14.7.1 Pre-COVID-19 Market Scenario
    • 14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.8 LAMEA Market Size Estimation and Forecast By Therapeutic
    • 14.8.1 Pre-COVID-19 Market Scenario
    • 14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.9 Brazil Market Analysis
    • 14.9.1 Brazil Is The Only Latin American Country To Be Ranked Among The World's Top Pharmaceutical Markets
    • 14.9.2 Pre-COVID-19 Market Scenario
    • 14.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.10 South Africa Market Analysis
    • 14.10.1 The Pharmaceutical Market In South Africa Is The Biggest In Africa
    • 14.10.2 Pre-COVID-19 Market Scenario
    • 14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.11 Saudi Arabia Market Analysis
    • 14.11.1 Saudi Arabia is one of the most appealing markets in Middle East For Pharma Products
    • 14.11.2 Pre-COVID-19 Market Scenario
    • 14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.12 Turkey Market Analysis
    • 14.12.1 Government Initiative To Limit Importations And Boost The Local Production Of The Pharmaceutical Industries In Turkey
    • 14.12.2 Pre-COVID-19 Market Scenario
    • 14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.13 UAE Market Analysis
    • 14.13.1 The UAE Governments Are Also Focused On Minimising Their Reliance On Imported Pharmaceuticals
    • 14.13.2 Pre-COVID-19 Market Scenario
    • 14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
  • 14.14 Rest of LAMEA Market Analysis
    • 14.14.1 The Value Of Commercial Outsourcing Becomes Apparent In The Pharmaceutical Business In LAMEA
    • 14.14.2 Pre-COVID-19 Market Scenario
    • 14.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

15 Competitive Landscape

  • 15.1 Company Market Share Analysis
  • 15.2 Key Business Strategy Analysis
  • 15.3 New Product/Service Launch as the Key Business Strategy In the Global Market
  • 15.4 Acquisition as the Key Business Strategy In the Global Market
  • 15.5 Partnership as the Key Business Strategy In the Global Market
  • 15.6 Collaboration as the Key Business Strategy In the Global Market
  • 15.7 Expansion as the Key Business Strategy In the Global Market
  • 15.8 Agreement as the Key Business Strategy In the Global Market
  • 15.9 Contract as the Key Business Strategy In the Global Market

16 Leading Company Profiles

  • 16.1 Apodi Healthcare Limited
    • 16.1.1 Company Snapshot
    • 16.1.2 Company Overview
    • 16.1.3 Company Product Benchmarking
  • 16.2 CMIC Holdings Co., Ltd
    • 16.2.1 Company Snapshot
    • 16.2.2 Company Overview
    • 16.2.3 Company Financial Profile
    • 16.2.4 Company Product Benchmarking
    • 16.2.5 Company Recent Developments
  • 16.3 Syneos Health Inc.
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Company Financial Profile
    • 16.3.4 Company Product Benchmarking
    • 16.3.5 Company Recent Developments
  • 16.4 IQVIA Holdings Inc.
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Company Financial Profile
    • 16.4.4 Company Product Benchmarking
    • 16.4.5 Company Recent Developments
  • 16.5 Marvecs GmbH
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Company Product Benchmarking
  • 16.6 OnCall LLC
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Company Product Benchmarking
  • 16.7 Publicis Groupe SA
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Company Financial Profile
    • 16.7.4 Company Product Benchmarking
    • 16.7.5 Company Recent Developments
  • 16.8 Sofip
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Company Product Benchmarking
  • 16.9 UDG Healthcare PLC
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Company Financial Profile
    • 16.9.4 Company Product Benchmarking
    • 16.9.5 Company Recent Developments
  • 16.10 Amplity Health
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Company Product Benchmarking
    • 16.10.4 Company Recent Developments
  • 16.11 Granard Pharmaceuticals
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Company Product Benchmarking
  • 16.12 Vanguard Pharma
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Company Product Benchmarking
  • 16.13 GTS Solution
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Company Product Benchmarking
  • 16.14 MaBiCo (Contract Sales Organization)
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Company Product Benchmarking
  • 16.15 Sales Partnerships Inc.
    • 16.15.1 Company Snapshot
    • 16.15.2 Company Overview
    • 16.15.3 Company Product Benchmarking
  • 16.16 QFR Solutions
    • 16.16.1 Company Snapshot
    • 16.16.2 Company Overview
    • 16.16.3 Company Product Benchmarking

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks
  • 17.2 Recommendations

18 Glossary Terms

  • 18.1 List Of Other Notable Player
  • 18.2 List of Organization